Breakthrough's Comment On Research On Lapatinib Presented At The European Breast Cancer Conference
Main Category: Breast CancerAlso Included In: Conferences; Cancer / Oncology
Article Date: 22 Apr 2008 - 4:00 PDT
email to a friend 
printer friendly 
opinions
| Patient / Public: |  |
4.5 (2 votes) |
| Healthcare Prof: |  |
4 (1 votes) |
Early research presented at the European Breast Cancer Conference suggests that treatment with lapatinib prior to surgery may be beneficial for some patients with advanced HER2 positive breast cancer.
Dr Alexis Willett, Policy Manager at Breakthrough Breast Cancer says:
"Larger breast tumours can be difficult to treat surgically and for some women treatment to shrink the tumour beforehand may help. It is not yet clear whether lapatinib is more effective than currently used standard treatments for shrinking tumours and while these very early results are promising it's important to remember that this is a small study involving only 45 patients. We await further research on this with interest."
Breakthrough Breast Cancer
Visit our breast cancer section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/104930.php>
APA
http://www.medicalnewstoday.com/releases/104930.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy |
Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
